Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

It’s most frequently recognized disease-associated cause is diabetes. Gastroparesis occurs because the nerves that move food through the digestive tract are damaged, so muscles don’t work ...

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) ...

In addition to treating symptoms, prokinetic drugs could potentially improve glycemic control in diabetic gastroparesis by allowing a more predictable absorption of nutrients, matched to the ...

McCallum and colleagues studied whether mitemcinal, an orally administered motilin agonist, is effective at improving diabetes-related gastroparesis symptoms. The authors conclude that mitemcinal ...

The following is a summary of “Clinical study status of diabetic gastrointestinal diseases,” published in the April 2025 ...

These pulses can help improve symptoms like nausea and vomiting. Only people with gastroparesis caused by diabetes or an unknown cause, for whom medications are not effective, should use GES as a ...

The analysis focused on adults who were obese, with a body mass index higher than 30, but who did not have a diagnosis of ...

Nerve damage from diabetes isn’t reversible. But you may be able to stop neuropathy from getting worse, or possibly eliminate symptoms as if you’re not living with this complication anymore.

Gastric Electrical Stimulators MarketThe global gastric electrical stimulators market is forecast to grow from USD 270.8 million in 2025 to an estimated USD 488.3 million by 2035, expanding at a ...